Demand for Noninvasive Fat Reduction Is Plummeting
This article is based on a piece that originally ran on Jolene Edgar's Substack, Aesthetics Unfiltered.
The American Society of Plastic Surgeons' (ASPS) annual trend-spotting report has arrived, plotting the popularity of plastic surgery and noninvasive procedures. Every year, it analyzes key shifts in aesthetic medicine—and never fails to provide a juicy surprise or two.
The 2024 installment that just came out had a few highlights: Demand for cosmetic interventions mostly held steady across the surgical and minimally invasive categories, without any major spikes. While facelifts and related glow-ups like brow lifts and lip lifts dominated on social media, the most popular plastic surgery procedures in ORs were actually butt and thigh lifts and, interestingly enough, cheek implants, each recording a three percent uptick from the previous year. In the nonsurgical realm, neuromodulators (like Botox, Xeomin, and Dysport) and hyaluronic acid fillers (such as Restylane and Juvéderm) claimed the top two spots, respectively. Next up, people were getting more skin resurfacing treatments (peels, lasers, microdermabrasion), which came in third, up six percent from 2023.
What caught my eye, though, was a far bigger number in the % CHANGE 2024 vs 2023 column: negative 40%. It's the data equivalent of a free fall, and it was attached to the number of noninvasive fat reduction procedures—CoolSculpting, Vanquish, Kybella, and the like—performed by plastic surgeons year-over-year. They fell from 745,967 in 2023 to 447,581 in 2024.
What's most surprising about the drop-off, according to some doctors, is the sheer fact that it took so long to transpire. When I posted on Instagram about the rapid decline, plastic surgeons replied with comments like, 'Finally!' and 'Thank god!' Consider the track record of these treatments—some are as famous for complications as results—and factor in the Ozempic phenomenon, and you can perhaps see why these methods for freezing or heating or otherwise killing fat cells have begun to fall from favor.
Noninvasive fat reduction procedures are down 40%, the data equivalent of a free fall.
Bob Basu, MD, a board-certified plastic surgeon in Houston and the president-elect of the ASPS, attributes what he calls the 'steep decline' to both the GLP-1 boom and what he sees as the modern patient's bang-for-buck mentality.
'The rise of GLP-1 medications for weight loss has fundamentally changed the landscape,' Dr. Basu says. By targeting visceral fat—'the deep intra-abdominal fat [cushioning our organs] that no plastic surgery or device can reach,' he explains—these drugs deliver wholly transformative results. And since people who lose considerable weight are typically left with loose, hanging skin, they're shifting focus to refining their shape and tightening their skin with both surgical nips and tucks as well as minimally invasive skin-tightening modalities, he says. (These can include radiofrequency treatments, like Renuvion and BodyTite.)
In addition to performing surgical lifts to remove excess tissue from the arms, thighs, breasts, back, and abdomen, 'we're very busy doing liposuction in patients who've lost significant quantities of fat with the GLP-1s,' says Darren Smith, MD, a board-certified plastic surgeon in New York City. Why would someone who's already slimmed down need lipo? 'These are very nuanced cases, where [the patient] has lost a bunch of weight, but there's still a fat deposit with a complex anatomy that requires a customized approach,' he explains. This person might want to remove stubborn fat—from, say, the hips or thighs—that persists even after they lose weight on a GLP-1, for example. Also, lipo is generally about contouring, not strictly debulking.
While nonsurgical fat-reducing treatments—which aim to destroy fat cells so the body can then eliminate them—'can be effective for small, localized areas,' notes Dr. Basu, 'they often require multiple sessions and don't address skin laxity or significant volume loss [that comes with taking a GLP-1].' He believes this puts them at a disadvantage with today's 'value-conscious' patients who, 'in the wake of ongoing economic uncertainty,' are more carefully weighing the risks and rewards of cosmetic procedures.
While every cosmetic intervention poses some degree of risk, CoolSculpting has made headlines for its complications. One of the more serious risks of the fat-freezing technology is paradoxical adipose hyperplasia (PAH), which is marked by fat growth in treatment areas. While PAH was first reported in 2014, it didn't achieve mainstream notoriety until 2021 when Linda Evangelista shared what she called her 'brutally disfigur[ing]' experience with CoolSculpting and sued the makers of the device for $50 million in damages.
In a time of economic uncertainty, patients are more carefully weighing the risks and rewards of cosmetic procedures.
A potentially devastating complication, PAH presents as abnormal bulges—usually hard, sometimes painful, and frequently shaped like the device applicator. Its victims typically see their treatment areas shrink as expected, but then, weeks later, grow bigger than they were pre-freeze. The only fix for PAH is surgery—energy-assisted liposuction and/or a tummy tuck—to address the fibrotic fat (a firm type of fat that can be challenging to remove) and restore normal contours.
The incidence of PAH is low, but thought by some to be underreported. 'While one review [of more than 2,000 CoolSculpting patients] cited [PAH] rates ranging from 0.05% to 0.39%—compared to the manufacturer's noted rate of 0.025%—even these values are likely artificially low due to underreporting and other factors,' says board-certified New York City plastic surgeon Alan Matarasso, MD. Some patients don't report the problem, assuming they simply gained weight after the procedure. It's easy to imagine this scenario unfolding in cases where patients haven't been briefed on the risks of CoolSculpting prior to treatment. While the informed consent process is standard in doctors' offices, this review of risks and benefits may be skipped altogether when CoolSculpting is performed in a med spa or salon.
'CoolSculpting, rightfully, has gotten some very bad press, and the risks associated with it have become much more apparent, so I think people are less likely to perceive it as this risk-free way to have body contouring,' says Dr. Smith. 'Not only are fewer people turning to CoolSculpting [due to the risks], even in a vacuum, but very few post GLP-1 weight-loss patients are good candidates for the procedure,' he continues. 'And since CoolSculpting does, or did, account for such a large proportion of the noninvasive fat-removal market, that will account for a significant portion of the overall decline' in the category. Allure reached out to the manufacturers of CoolSculpting, who did not send a comment by press time.
In 2024, Dr. Smith co-authored the largest case series of PAH to date. Published in the Aesthetic Surgery Journal (ASJ), the paper details the cases of 33 patients with the complication. All required power-assisted liposuction, which pairs vibration with suction for more efficient fat removal; one patient, who'd undergone six rounds of CoolSculpting, needed a tummy tuck in addition to lipo. Twenty-eight percent of study subjects required multiple surgeries to correct their PAH.
The study highlights the case of a 30-year-old, who developed PAH after having her inner thighs treated at a med spa. When she returned to the spa for help, the technician attempted to solve the problem with the only tools at her disposal—more CoolSculpting plus two rounds of fat-dissolving deoxycholic acid injections (aka Kybella). When those interventions failed, the woman took it upon herself to consult with a plastic surgeon about a more effective strategy for correcting PAH: Surgery, the very thing she was aiming to avoid when she signed up for CoolSculpting.
'It is unfortunate and ironic that patients seeking a noninvasive body contouring treatment are those left with potentially severe contour deformities necessitating aggressive surgical management for resolution,' Dr. Matarasso says. If you're considering CoolSculpting or any noninvasive fat reduction procedure, it's best to see an experienced board-certified plastic surgeon or dermatologist, who acknowledges all of the potential risks and complications and is fully equipped to manage them should they occur.
Read more about body contouring and plastic surgery:
The Most Popular Plastic Surgery Procedure Says a Lot About Our Culture Right Now
17 People Get Real About Their Mommy Makeovers
Linda Evangelista Shared the First Photos of Her Body Following a Cosmetic Procedure Gone Wrong
Originally Appeared on Allure
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Man who killed police officer 'blamed COVID jab for making him depressed and suicidal'
A man who opened fire on the headquarters of America's national public health agency - leaving a police officer dead - had blamed the COVID vaccine for making him depressed and suicidal. Patrick Joseph White, a 30-year-old from Georgia, had tried to enter the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta but was stopped by guards, a law enforcement official said. They added that White then drove to a pharmacy across the street before opening fire late on Friday afternoon. He was armed with five guns - including at least one long gun. DeKalb County Police Officer David Rose, who had three children, was shot dead while responding to the incident. White also died, but authorities haven't said whether he was killed by police or if he killed himself. His father had contacted police and identified his son as the possible gunman. White's father also said his son had been upset over the death of his dog and had become fixated on the COVID-19 vaccine. Health and Human Services Secretary Robert F. Kennedy Jr, whose scepticism of vaccines has been a cornerstone of his career, voiced support for CDC employees yesterday. But some laid-off CDC employees said Mr Kennedy shares responsibility for the violence and should resign. Mr Kennedy has a history as a leader in the anti-vaccine movement, but he reached new prominence by spreading distrust of COVID-19 vaccines. For example, he called it "criminal medical malpractice" to give these jabs to children. He said after the shooting: "We are deeply saddened by the tragic shooting at CDC's Atlanta campus that took the life of officer David Rose. "We know how shaken our public health colleagues feel today. No one should face violence while working to protect the health of others." Sarah Boim, a former CDC communications staffer who was fired this year during a wave of terminations, said the shooting was the "physical embodiment of the narrative that has taken over, attacking science, and attacking our federal workers". White's 'distrust of COVID vaccines' A neighbour of White told The Atlanta Journal-Constitution that the gunman spoke with her multiple times about his distrust of COVID-19 jabs. Nancy Hoalst, who lives on the same street as White's family, said he seemed like a "good guy" but he would bring up vaccines even in unrelated conversations. "He was very unsettled, and he very deeply believed that vaccines hurt him and were hurting other people." Ms Hoalst told the Atlanta newspaper. "He emphatically believed that." However, she said she never believed White would be violent and added: "I had no idea he thought he would take it out on the CDC."
Yahoo
an hour ago
- Yahoo
Spotting One of These Sneaky Stomach Cancer Symptoms Could Save Your Life, Doctors Say
If you naturally associate stomach cancer with brutally painful stomachaches, you're not the only one. And yet, stomachaches are not typically a sign of this rare form of cancer at any point in its progression. Instead, the most common feature of the early stages of stomach cancer is that there are no symptoms at all, said Umut Sarpel, M.D., the chief of the division of surgical oncology at Beth Israel Deaconess Medical Center in Boston. "We all get stomachaches from time to time, and that can make people worry about stomach cancer," Dr. Sarpel said. "But it's not one of the most common cancers, and in most cases, stomachaches or pain are not going to be the result of cancer." Meet the expert: Umut Sarpel, M.D., the chief of the division of surgical oncology at Beth Israel Deaconess Medical Center in Boston. So what are the signs of stomach cancer? When it causes any, they are typically one of these six digestive problems. There is blood in your vomit or stool. While both colitis and Crohn's disease can cause bloody stool, it can also be a sign of cancer. Regardless, blood in either your poop or your vomit demands a visit to a GI doctor, Dr. Sarpel said. If the bleeding is related to cancer, the blood in your stool is likely to look maroon or tarry black. "It looks that way because it's been acted on by your digestive enzymes," she explained. If the blood is in your vomit, it's more likely to look bright red, and it may have a coarse "coffee grounds" texture because it has been partially digested, Dr. Sarpel added. You feel full after just a few bites. You were definitely hungry when you sat down to eat. But after a few bites, your appetite vanishes and the food isn't appealing. Dr. Sarpel called this "early satiety," and says it's another symptom that could—emphasis on could—indicate stomach cancer. "Especially if feeling full really quickly is different than what you're used to, that's something you shouldn't ignore," she said. You have constant, gnawing stomach pain. Yes, in some cases stomach pain is a sign of stomach cancer. But in most cases, your run-of-the-mill pain or stomach cramps are going to be the result of some other gut or abdominal ailment, not cancer, Dr. Sarpel said. If it is a result of cancer, the pain will be a consistent gnawing in the middle of your stomach, she added. "It's not something you feel for one day, and then it goes away for two weeks and comes back again." You lost weight without trying. Many health conditions—including type 1 diabetes, Addison's disease, and Crohn's disease—can lead to unexplained weight loss. Add stomach cancer to that list, Dr. Sarpel said. "If you're losing weight and not dieting, that's something to pay attention to," she explained. Be aware that the weight loss may be gradual. While you may not notice a sudden drop, you might step on a scale and find you've lost 10 pounds during the last 6 months. It is totally natural for your weight to fluctuate, but if the weight loss is noticeable and you haven't been doing anything that accounts for it, talk with your doctor. You have frequent, unexplained heartburn. Heartburn, indigestion, and other common symptoms of an unhappy gut can also be early warning signs of stomach cancer, according to the MD Anderson Cancer Center at the University of Texas. Again, Dr. Sarpel said these sorts of symptoms are much more likely to be something other than cancer. But it's still a good idea to let your doctor know what's going on, especially if they are constant and don't seem to be caused by consumption of specific foods and drinks. You experience regular bloating, diarrhea, and constipation. It makes sense that a cancer growing in your stomach could make you feel bloated, or mess with your bowel movements. While each of these symptoms is never going to scream "stomach cancer!" to a doctor, experiencing them with some of the other issues on this list—especially if you have other stomach cancer risk factors, like being over 60, being overweight or obese, having a history of smoking, or having had stomach surgery in the past—could lead to cancer-related follow-up testing if your doctor can't pinpoint another explanation. You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50 Solve the daily Crossword
Yahoo
2 hours ago
- Yahoo
Wells Fargo Sticks with Overweight on UnitedHealth (UNH), Trims Target to $267
UnitedHealth Group Inc. (NYSE:UNH) is one of the best defensive stocks to invest in according to analysts. At the time of writing this article, UnitedHealth ranks among the 10 biggest year-to-date decliners, which have lost over 50% among U.S.-listed stocks with a market capitalization exceeding $2 billion. The company, which was marred by government investigations, operational failures, and leadership changes, reported mixed Q2 2025 earnings results at the end of July. Those results have been unable to shore up the share price, as the long-term growth outlook is still murky. A close-up of a healthcare professional studying a computer screen with data while consulting with a patient. The company guided for 2025 adjusted EPS to be over $16, which was significantly below Bloomberg's consensus expectations of $20.4. Seeing the brighter side, Jeff Jonas, portfolio manager at Gabelli Funds, called the guidance highly conservative and believes that it will be easier for the company to beat such low expectations. However, the steep correction and valuation discount have attracted analysts' interest, with around two-thirds of them having a Buy or equivalent rating. One of the analysts who maintains an optimistic view is Wells Fargo's Stephen Baxter. On August 4, Baxter maintained an Overweight rating on UnitedHealth but lowered his price target to $267 from $306. The revision followed a recently held management meeting where he assessed the company's updated outlook. According to the analyst, UnitedHealth's management remains confident in the company's ability to meet its reset 2025 guidance. In his view, management is taking a cautious but disciplined approach in factoring in cost trends and margin recovery. Baxter views this conservatism positively, suggesting it reduces the risk of further downside revisions. UnitedHealth Group Inc. (NYSE:UNH) is a healthcare company that provides health insurance and healthcare solutions in the U.S. and globally under the UnitedHealthcare and Optum brands. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Most Oversold S&P 500 Stocks So Far in 2025 and 10 Most Oversold Semiconductor Stocks So Far in 2025. Disclosure: None. This article is originally published at Insider Monkey.